scholarly journals Tracking Lower Urinary Tract Symptoms and Tamsulosin Side Effects Among Older Men using the PERSONAL app: Feasibility and Usability Study (Preprint)

10.2196/30762 ◽  
2021 ◽  
Author(s):  
Austin W Lee ◽  
Stacey A Kenfield ◽  
Elizabeth Y Wang ◽  
Anthony Enriquez ◽  
Akinyemi Oni-Orisan ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Side Effects ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Older Men ◽  
Usability Study ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

scholarly journals Co‐Occurrence of Lower Urinary Tract Symptoms and Frailty among Community‐Dwelling Older Men

2020 ◽  
Vol 68 (12) ◽  
pp. 2805-2813
Author(s):  
Scott R. Bauer ◽  
Rebecca Scherzer ◽  
Anne M. Suskind ◽  
Peggy Cawthon ◽  
Kristine E. Ensrud ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Older Men ◽  
Community Dwelling ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

scholarly journals Drugs used in prostatic enlargement and lower urinary tract symptoms: unseen and overlooked effects on sexual health

2019 ◽  
Vol 9 (3) ◽  
pp. 240-247
Author(s):  
SM Ashrafuzzaman ◽  
Muhammad Abdur Rahim ◽  
Zafar Ahmed Latif
Keyword(s):  
Urinary Tract ◽  
Side Effects ◽  
Lower Urinary Tract Symptoms ◽  
Side Effect ◽  
Lower Urinary Tract ◽  
Reductase Inhibitors ◽  
Adrenergic Antagonist ◽  
Urinary Tract Symptoms ◽  
Prostatic Enlargement ◽  
Lower Urinary

Benign prostatic hyperplasia (BPH) is one of the most common genitourinary complications in men over 50 years of age and typically presents with lower urinary tract symptoms (LUTS) and may need medical and occasionally surgical interventions. Few of them may only need advice on behavioral modification like less water intake after sunset, avoid tea, coffee after evening, avoid alcohol and less use of diuretics. The symptoms related to BPH or LUTS without any prostatic enlargement are incomplete voiding, frequency, intermittency, urgency, weak stream, straining and nocturia. For most patients with mild to moderate symptoms of BPH [International Prostate Symptom Score (IPSS) <8 or 8-19 respectively] monotherapy with an á-1-adrenergic antagonist remains initial treatment. The choice of specific á-adrenergic antagonist agent is generally based on cost and side effect profile. Other classes of medications include 5á-reductase inhibitors and phosphodiesterase (PDE) 5 inhibitors. In men who have mild to moderate symptoms of BPH and concomitant erectile dysfunction (ED), PDE-5 inhibitors are reasonable alternative. Now a days á-1-adrenoceptor blockers and 5á-reductase inhibitors are often combined to give a synergistic effect. A review of the current literature identified several adverse sexual side effects, including ED, decreased libido, orgasmic disorders and ejaculatory disorders. It is important to know the extent of these side effects, as the clinician and patient will need to decide the cost of improved voiding symptoms. The prime adverse effect is ejaculatory disorders including the absence of ejaculation. Clinical consideration for BPH/LUTS should include the elements of male sexual function, patient’s age and the characteristics and comprehensive effects of each group of drugs. Methodological bias in clinical studies, such as the subjective evaluation of the sexual side effect makes it difficult to determine the ideal drug for treatment. Men without ED or irritant symptoms who desire medical therapy but cannot tolerate á-1-adrenergic antagonists and do not have predominately irritant symptoms or concomitant ED, treatment with a 5á-reductase inhibitor is a reasonable. Treatment for 6 to 12 months is generally needed before prostate size is sufficiently reduced to improve symptoms. Symptoms are usually reversible, so drugs may need to be continued for long time or indefinitely under supervision of specialist. Birdem Med J 2019; 9(3): 240-247

SERUM ANDROGENS AND RISK OF LOWER URINARY TRACT SYMPTOMS IN COMMUNITY DWELLING OLDER MEN

2009 ◽  
Vol 181 (4S) ◽  
pp. 526-526
Author(s):  
J. Kellogg Parsons ◽  
Michael D Trifiro ◽  
Jaclyn Bergstrom ◽  
Kerrin Palazzi-Churas ◽  
Elizabeth Barrett-Connor
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Older Men ◽  
Community Dwelling ◽  
Urinary Tract Symptoms ◽  
Serum Androgens ◽  
Lower Urinary

Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: The MrOS study

Urology ◽  
2006 ◽  
Vol 68 (4) ◽  
pp. 804-809 ◽  
Author(s):  
Brent C. Taylor ◽  
Timothy J. Wilt ◽  
Howard A. Fink ◽  
Lori C. Lambert ◽  
Lynn M. Marshall ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Older Men ◽  
Urinary Tract Symptoms ◽  
Lower Urinary
Sign in / Sign up

Export Citation Format

Share Document